Industrial Policy & Trade Monitor· 2663 actions· ✨ 89 recent

On 27 January 2026 the European Union and India announced the conclusion of negotiations on a comprehensive Free Trade Agreement at the EU-India summit hosted at Hyderabad House in New Delhi, attended by PM Narendra Modi, Commission President Ursula von der Leyen and Council President António Costa. The deal — described by both leaders as the "mother of all deals" — covers ~25% of world GDP and ~2 billion people. The EU eliminates duties on 91% of tariff lines (covering 99.3% of bilateral trade by value); India eliminates duties on 86% of lines (covering 96.6% by value). Headline cuts include Indian tariffs on EU wines (150% → 75% at entry into force, falling to 20%), olive oil (45% → 0% over five years) and processed agri-food (up to 50% eliminated); EU tariffs are reduced/eliminated on Indian textiles, leather/footwear, gems and jewelry, marine products, tea, coffee, spices and certain agricultural and steel products. The agreement still requires Council adoption, European Parliament consent and approval by India's Union Council of Ministers; entry into force is expected in early 2027. Companion instruments concluded at the same summit include an EU-India Security and Defence Partnership and a Mobility and Migration Agreement.

On 1 February 2025, Finance Minister Nirmala Sitharaman announced the National Manufacturing Mission (NMM) in the Union Budget 2025-26 as a horizontal umbrella framework extending the 2014 "Make in India" architecture across small, medium and large industries. The mission rests on five focal areas: (i) ease and cost of doing business; (ii) a future-ready workforce for in-demand jobs; (iii) a vibrant and dynamic MSME sector; (iv) availability of technology; and (v) quality manufacturing. It will deliver policy support, execution roadmaps, and a governance/monitoring framework binding central ministries with states. NMM specifically commits to building a clean-tech manufacturing ecosystem with explicit coverage of solar PV cells, EV batteries, motors and controllers, electrolysers, wind turbines, very-high-voltage transmission equipment, and grid-scale batteries — i.e., the full hardware stack for India's Panchamrit (500 GW non-fossil by 2030), FAME-III EV ramp, and National Green Hydrogen Mission. NMM is the first horizontal Indian manufacturing-mission instrument in the IPTM register; existing IND entries are sector-specific PLIs (electronics, batteries, steel, semiconductors) and the National Critical Mineral Mission. Operational rollout flows through subsequent Cabinet-level scheme approvals (e.g. Biopharma SHAKTI ₹10,000 cr, Chemical Parks ₹600 cr in BE 2026-27); the mission itself does not carry a single headline outlay because it is the framework rather than an instrument.

On 29 January 2025 the Union Cabinet of India approved the National Critical Mineral Mission (NCMM), a seven-year programme running FY2024-25 through FY2030-31 with a headline financial envelope of ₹34,300 crore (≈USD 4.0 bn). The structure is split: ₹16,300 crore of direct government outlay administered by the Ministry of Mines, plus an expected ₹18,000 crore of investment by central public-sector undertakings (PSUs) and other stakeholders. The mission was first announced by the Finance Minister in the Union Budget 2024-25 (23 July 2024) and the Cabinet approval gave it formal sanction. The NCMM covers the full critical-minerals value chain: domestic exploration, mining, beneficiation, processing, recycling from end-of-life products, and acquisition of overseas mineral assets. The Geological Survey of India (GSI) is tasked with executing 1,200 exploration projects over the seven-year window (vs. 368 projects over the prior three years), expanded to offshore polymetallic-nodule provinces containing cobalt, REE, nickel and manganese. More than 100 critical-mineral blocks are slated for auction. Khanij Bidesh India Ltd (KABIL) — the JV of NALCO, HCL and MECL — is the designated vehicle for overseas acquisitions, with active Argentina lithium (CAMYEN SE, 15,703 ha) and Australia lithium/cobalt off-take pipelines. India's official critical-minerals list contains 30 commodities, of which 24 are inscribed in Part D of Schedule I of the MMDR Act 1957 (after the 2023 amendment), reserving central-government auction authority over them. The NCMM sets an explicit recycling target of 15-20% of domestic critical-mineral demand met from secondary sources (e-waste, battery scrap, industrial waste) by 2035. The mission also funds a National Centre of Excellence for Critical Minerals and offers customs-duty waivers on 25 critical minerals (announced in the same FY24-25 budget) to lower import costs while domestic capacity scales. NCMM is India's pull-side complement to the US IRA, EU Critical Raw Materials Act, Canada Critical Minerals Strategy and Australia Critical Minerals Strategy — a coordinated allied response to Chinese dominance over refined cobalt, REE, graphite and gallium/germanium. For India specifically it is framed as the supply-chain underpinning for FAME-III (EV adoption), the Semicon India programme (gallium/germanium/silicon), and the National Solar Mission (silicon, indium, tellurium, gallium for thin-film PV).

On 4 January 2023 the Union Cabinet of India, chaired by Prime Minister Narendra Modi, approved the National Green Hydrogen Mission with an initial financial outlay of ₹19,744 crore (≈USD 2.3 bn) covering FY2023-24 through FY2029-30. The bulk of the outlay — ₹17,490 crore — funds the Strategic Interventions for Green Hydrogen Transition (SIGHT) programme for electrolyser-manufacturing incentives and green-hydrogen production incentives. ₹1,466 crore is allocated to pilot projects (steel, mobility, shipping, ports, decentralised hydrogen), ₹400 crore to R&D, and ₹388 crore to other Mission components (skilling, regulatory framework, certification). The Ministry of New and Renewable Energy (MNRE) is the lead implementing agency. Headline targets by 2030: at least 5 MMT/year of domestic green-hydrogen production capacity, with ≈125 GW of associated additional renewable- energy capacity, mobilisation of >₹8 lakh crore (≈USD 100 bn) of total investment, creation of >600,000 jobs, and avoidance of ≈50 MMT/year of CO₂ emissions. The Mission is positioned as the supply-chain underpinning for India's hard-to-abate decarbonisation (refining, fertilisers, steel) and as the basis for a green-hydrogen export industry leveraging India's low-cost solar resource. MNRE notified the SIGHT scheme guidelines on 28 June 2023, splitting the programme into Component I (Electrolyser Manufacturing Incentive, ₹4,440 crore) and Component II (Green Hydrogen Production Incentive, ₹13,050 crore for Mode-1; subsequent Mode-2A and Mode-2B tranches added for sector-specific tenders). Solar Energy Corporation of India (SECI) is the implementing agency for both components and runs the competitive reverse-auction tenders.

The Union Cabinet on 12 May 2021 approved the Production-Linked Incentive (PLI) Scheme "National Programme on Advanced Chemistry Cell (ACC) Battery Storage" with a Rs 18,100 crore (~USD 2.4 bn) outlay over five years to build 50 GWh of ACC and 5 GWh of "Niche" ACC manufacturing capacity in India. Selected bidders receive PLI cash incentives over five years on sale of cells made in India, gated on minimum 25% domestic value addition rising to 60% by year five and chemistry-agnostic eligibility (Li-ion, Na-ion, solid-state, flow, lead-acid). The MHI awarded the first 50 GWh tranche on 24 March 2022 (Hyundai Global Motors 20 GWh, Ola Electric 20 GWh, Reliance New Energy Solar 5 GWh, Rajesh Exports 5 GWh) under a QCBS global tender; the Hyundai Global Motors award was withdrawn after Hyundai Motor Company disowned the bidder in August 2022, triggering a re-tender of the orphaned capacity that completed in 2025.

The Department of Pharmaceuticals notified the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs), Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) on 21 July 2020 via Gazette Notification, with an outlay of Rs 6,940 crore (~USD 920m) over FY 2020-21 to FY 2027-28. The scheme covers 41 identified critical bulk-drug products across four target segments — fermentation-based (Key Fermentation; Niche Fermentation) and chemical synthesis-based (Key Chemical Synthesis; Niche Chemical Synthesis) — paying 20% incentive on incremental sales for fermentation-based products (years 1-4) tapering to 15% (year 5) and 5% (year 6), and a flat 20% over 5 years for chemically-synthesised products. The stated objective is to reduce India's ~70% bulk-drug import dependence on China by establishing greenfield domestic manufacturing capacity with at least 90% domestic value addition for fermentation products and 70% for chemical-synthesis products.